Recently, the availability of long-acting release Octreo tide (OCT-LAR) for monthly intramuscular administration has become an interesting therapeutic alternative.


 To report the case of an infant with UGIB due to PHT who was successfully treated with OCT-LAR.


 As neither endoscopic nor surgical treatment were feasible, we decided to start IM OCT- LAR monthly. 
OCT-LAR
Recently, the availability of long-acting release Octreo tide (OCT-LAR) for monthly intramuscular administration has become an interesting therapeutic alternative.


 To report the case of an infant with UGIB due to PHT who was successfully treated with OCT-LAR.


 As neither endoscopic nor surgical treatment were feasible, we decided to start IM OCT- LAR monthly. 
OCT-LAR
Long-acting Release Octreotide for Pediatric Upper Gastrointestinal Bleeding.INTRODUCTION
 The usual treatment in these cases includes intravenous Octreotide.  Recently, the availability of long-acting release Octreo tide (OCT-LAR) for monthly intramuscular administration has become an interesting therapeutic alternative.


 Eight-month-old patient with repeated episodes of UGIB due to extrahepatic portal vein malformation, requiring blood transfusions, and intravenous octreotide infusions. 
Octreotide